Skip to main content

Table 1 Demographics and ocular historya

From: Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival

Variable Study Group
(N = 19)
Control Group
(N = 19)
P-value
Age, years 29.21 (±9.1) 33.61 (±11.0) 0.19
Genderb
 Male (10) 2 (20.0%) 8 (80.0%) 0.09
 Female (12) 7 (58.3%) 5 (41.7%)
Pre-Trabeculectomy:
LogMAR 0.68 (±0.5) 0.86 (±0.9) 0.10
Mean IOP before Trabeculectomy, mmHg 40.05 (±9.1) 39.16 (±8.4) 0.76
Mean number of antiglaucoma medications before Trabeculectomy 3.95 (±0.6) 3.74 (±0.7) 0.35
Concentration of MMC
 0.02% (0.2 mg/ml) MMC 13 9 0.16
 0.04% (0.4 mg/ml) MMC 6 10
Duration of MMC exposure (min)
 0.02% (0.2 mg/ml) MMC 3.23 (±0.9) 3.00 (±0.7) 0.54
 0.04% (0.4 mg/ml) MMC 3.33 (±0.5) 3.10 (±0.3) 0.28
Time to cataract surgery/study entry, months 33.21 (±33.3) 35.79 (±36.6) 0.82
Gonioscopy status
 Open 14 (73.7%) 9 (47.4%) 0.09
 Closed 5 (26.3%) 10 (52.6%)
Follow-up, months 45.75 (±36.4) 50.33 (±38.9) 0.71
  1. aData are presented as mean (±SD) and frequencies (%). Numbers are per eyes
  2. bNumbers are per patients
  3. P-values were calculated using Student t-test, Mann-Whitney U test and Chi-Square test